clinical trials
Positive topline results announced in phase 2 Alcohol Use Disorder study
January 29, 2025Research and Development Beckley Psytech Ltd, King's College University, Poisoning and drug dependency, alcohol use disorder, clinical trials, positive results
Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has …
Results from Novadip phase 1b/2a trial reveal 88% efficacy
January 28, 2025Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases
Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …
NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink
November 5, 2024Research and Development NorthWest Ehealth, clinical trials
The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …
Chiesi announces phase 3 results from enzyme-replacement study
October 29, 2024Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases
Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …
Calliditas Therapeutics announces positive phase 2b data in Primary Biliary Cholangitis trial
July 26, 2024Research and Development Calliditas, Hepatology, clinical trials, elevated liver stiffness, primary biliary cholangitis
Calliditas Therapeutics AB today announced that the phase 2b TRANSFORM trial met its primary endpoint. The trial showed statistically significant …
AC Immune’s pTau-targeting immunotherapy awarded Fast Track designation by FDA
July 26, 2024Research and Development AC Immune, Alzheimer's disease, Neurology, clinical trials, fast track designation, immunotherapy, tau protein
Clinical-stage biopharmaceutical company AC Immune announced that the US Food and Drug Administration (FDA) has granted its Alzheimer’s disease (AD) …
60 Degrees Pharmaceuticals signs clinical trial agreements with sites for babesiosis study
July 22, 2024Medical Communications 60 Degrees Pharmaceuticals, Pharmacy, babesiosis, clinical trials
60 Degrees Pharmaceuticals has announced that it has signed clinical trial agreements with all three of its planned trial sites …
Pfizer selects once-daily obesity drug for advancement
July 12, 2024Research and Development Obesity, Pfizer Inc, clinical trials, obesity
Pfizer has announced the selection of its preferred once-daily modified release formulation for danuglipron, with a plan to conduct dose …
Arcturus Therapeutics provides update on OTC deficiency and CF programmes
July 2, 2024Research and Development Arcturus Therapeutics, OTC, Pharmacy, clinical trials, cystic fibrosis
Arcturus Therapeutics has announced mid-year updates for ARCT-810, an investigational mRNA therapeutic to treat ornithine transcarbamylase (OTC) deficiency, and ARCT-032, …
IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer
June 27, 2024Research and Development IDEAYA Biosciences, Oncology, bladder cancer, clinical trials, oncology
Precision medicine oncology company IDEAYA Biosciences has announced that the first patient in the IDEAYA-sponsored phase 1 trial has been …
Gilead shares results from two-year analysis of phase 3 study in primary biliary cholangitis
June 5, 2024Research and Development Gilead, Hepatology, clinical trials, primary biliary cholangitis, seladelpar
Gilead has announced two-year interim results from the ongoing ASSURE study of investigational seladelpar for the treatment of primary biliary …
Rare disease clinical trials: the urgent need for patients to be heard
May 22, 2024Alexion, Pharmafocus, Rare Diseases, clinical trials, feature
Ahead of Clinical Trials Day, Soraya Bekkali, from Alexion, AstraZeneca Rare Disease, highlights the urgent need to elevate patients’ voices …
NeuroSense partners with PhaseV on upcoming phase 3 ALS trial
May 16, 2024Research and Development NeuroSense, Neurology, als, clinical trials
NeuroSense has announced that it has partnered with PhaseV for its upcoming phase 3 trial of PrimeC as a treatment …
Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study
May 9, 2024Research and Development Alzheimer's disease, Neurocrine Biosciences, Neurology, Nxera Pharma, Parkinson's disease, clinical trials, dementia, schizophrenia
Nxera Pharma’s neuroscience-focused biopharmaceutical partner Neurocrine Biosciences has announced it has successfully started its phase 1, first-in-human trial of investigational …
Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet
May 8, 2024Research and Development Hepatology, Mirum Pharmaceuticals, PFIC, The Lancet, clinical trials
Biopharma company Mirum Pharmaceuticals has announced data from its phase 3 MARCH-PFIC study which evaluated maralixibat in patients with progressive …
Latest content
Five Facts about cardiovascular disease
